Results
2
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
Gubra
Market Cap: DKK 6.4b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 392.40
7D
-0.9%
1Y
-26.0%
ChemoMetec
Market Cap: DKK 11.0b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 631.50
7D
17.8%
1Y
51.7%